Nebivolol Versus Metoprolol: Comparative Effects on Fatigue and Quality of Life

Completed · Phase 4

Conditions studied: Hypertension

In brief

Beta-blockers are prescribed to millions of people for treatment of hypertension. Fatigue is a recognized and common side effect of beta-blockers that can have significant effects on quality of life. Worse, many people taking a beta-blocker for years are not even aware of the reduction of energy with which they are living. A new vasodilating beta-blocker, nebivolol, which is approved by the FDA for treatment of hypertension, appears to be far less associated with fatigue than are most currently available beta-blockers. The purpose of this study is to compare nebivolol with the current best-selling beta-blocker, metoprolol, and determine whether there is a significant difference in side effects including fatigue, reduced exertion tolerance, and reduced quality of life. In this study, 30 subjects will take each of the 2 study drugs for 8 weeks, consisting of 4 weeks at a lower dose, and 4 weeks at a higher dose. All dosages are FDA-approved for treatment of hypertension. Subjects and investigators will not know which drug is being administered until completion of the study. Subjects will undergo a treadmill stress test and will complete fatigue and quality of life questionnaires after each 4 weeks of treatment. An echocardiogram and non-invasive measurement of aortic blood pressure will be performed after 8 weeks on each drug. Also, blood will be drawn and stored for possible measurement of drug levels, after 4 and 8 weeks on each drug. Results on each drug will then be compared. If nebivolol is found to cause significantly less fatigue, it would be of substantial importance to the many millions of people who are on life-long beta-blocker therapy, and are living with reduced energy.

Key facts

Study ID

NCT00999102

Run by

Weill Medical College of Cornell University

People needed

37

Starts

2009-10-01

Expected to finish

2011-01-01

Last updated by the study team

2018-10-19

Who can join

Age: 21 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Individuals who are taking, or are about to begin taking, a beta-blocker, and who have the approved indication of hypertension

You may not qualify if…

• Orthopedic ailments that would interfere with performance of treadmill testing
• Stroke or heart attack within the previous 1 year
• Symptomatic coronary disease within the past year (angina, shortness of breath)
• Clinically significant pulmonary disease (e.g. emphysema or asthma).
• Poorly controlled hypertension (blood pressure above 160 systolic or 100 diastolic)
• Patients with contra-indications to taking a beta-blocker (asthma or bradyarrhythmia)
• History of tachyarrhythmia (abnormal rapid heart rate)

Where it is running

• Weill Cornell Medical College — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.